Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study

Overview of attention for article published in Annals of Oncology, February 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,394 followers.

Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma:… http://t.co/EPO5F7hP4N

ARTICLE: Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic... http://t.co/oY0zGx4vSl

Functional and symptom impact of trametinib vs CT in BRAF V600E m-melanoma: QoL analyses of METRIC study Ann_Oncology http://t.co/tErTmgmj6x

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.